• Read more about In silico modeling predicts drug sensitivity of patient-derived cancer cells

Glioblastoma (GBM) is an aggressive disease associated with poor survival.

• Read more about Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs

Glioblastoma (GBM) is a therapeutic challenge, associated with high mortality.